SMTL ID : 7bpi.1 (1 other biounit)

The crystal structue of PDE10A complexed with 14

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.40 Å

Oligo State

monomer

Ligands

1 x ZN: ZINC ION(Non-covalent)

ZN.1: 5 residues within 4Å: Chain A: H.77, H.81, H.115, D.116, D.226 5 PLIP interactions: 4 interactions with chain A, 1 Ligand-Water interactions Metal complexes: A:H.81, A:H.115, A:D.116, A:D.226, H2O.1

1 x MG: MAGNESIUM ION(Non-covalent)

MG.2: 2 residues within 4Å: Chain A: D.116, H.147 3 PLIP interactions: 1 interactions with chain A, 2 Ligand-Water interactions Metal complexes: A:D.116, H2O.1, H2O.1

1 x DZU: 8-[(E)-2-[5-methyl-1-[3-[3-(4-methylpiperazin-1-yl)propoxy]phenyl]benzimidazol-2-yl]ethenyl]quinoline(Non-covalent)

DZU.3: 14 residues within 4Å: Chain A: F.191, L.227, S.229, V.230, I.244, Y.245, F.248, M.265, E.273, V.274, G.277, Q.278, G.280, F.281 12 PLIP interactions: 12 interactions with chain A Hydrophobic interactions: A:V.230, A:I.244, A:Y.245, A:F.248, A:M.265, A:E.273, A:F.281, A:F.281 Hydrogen bonds: A:Y.245, A:Q.278 pi-Stacking: A:F.281, A:F.281

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Yang, Y. et al., Discovery of highly selective and orally available benzimidazole-based phosphodiesterase 10 inhibitors with improved solubility and pharmacokinetic properties for treatment of pulmonary arterial hypertension. Acta Pharm Sin B (2020)

Release Date

2021-01-27

Peptides

cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A

Related Entries With Identical Sequence